XIFAXAN® (rifaximin) For Adults with Overt HE and IBS-D XIFAXAN® (rifaximin) 550 mg tablets are indicated for the reduction in risk of overt hepatic encephalopathy (HE) recurrence in adults and for the treatment of irritable bowel syndrome with diarrhea (IBS-D) in adults
Overt Hepatic Encephalopathy| XIFAXAN® (rifaximin) Learn about Xifaxan, a prescription medication for the reduction in risk of overt hepatic encephalopathy recurrence in adults See Safety and Full Prescribing Information
Connect with Us | XIFAXAN® (rifaximin) Visit this page to connect with a Salix Pharmaceuticals representative and sign up to stay up to date on XIFAXAN® (rifaximin)